Gut Microbiota and Type 1 Diabetes Mellitus: The Effect of Mediterranean Diet

Cinzia Myriam Calabrese, Alessia Valentini, Giorgio Calabrese, Cinzia Myriam Calabrese, Alessia Valentini, Giorgio Calabrese

Abstract

Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease resulting from a complex interplay between genetic susceptibility and environmental factors. Regarding the latter, gut microbiota has a pivotal role in the pathogenesis of T1DM, by affecting intestinal permeability, molecular mimicry, and modulating innate and adaptive immune system, as described in several previous studies. The composition of the gut microbiota is largely influenced by diet. Some observational studies have shown that a low fiber intake is associated with the development of many inflammatory and immune-mediated diseases. In this context, the Mediterranean diet (MD), which is based on high consumption of cereals (preferably as whole grains), legumes, nuts, vegetables, fruits, olive oil, and fish, could play a protective role. Many of the characteristic components of MD have functional characteristics with positive effects on health and well-being. Eating habits are the main significant determinants of the microbial multiplicity of the intestine and the food components influence both microbial populations and their metabolic activities from the early stages of life. Moreover, food metabolites influence the immune response. The intestine is considered the primary site where food metabolites mediate their effects, through epithelial integrity or mucosal immunity. The compromised epithelial integrity allows the translocation of bacteria and/or the diffusion of their products, such as food antigens and lipopolysaccharides, from the intestinal lumen to the tissues, which could enhance the stimulation of immune cells, contributing to the pathogenesis of autoimmune diseases, such as T1DM. The intake of a high amount of fiber and therefore of prebiotics with MD allows the microbiota to have a good microbial balance. Moreover, as more dietary fibers are ingested, a higher amount of short-chain fatty acids (SCFAs) is produced by anaerobic gut microbiota, promoting gut homeostasis, to which also contribute tryptophan metabolites and omega-3-fatty acids. Furthermore, the higher intake of polyunsaturated fatty acids and omega-3-fatty-acids contribute to a better metabolic control. In this review we report the relationship between gut microbiota and T1DM and we explore the effects of Mediterranean diet on microbiota as a potential therapeutic strategy, aimed at preventing or delaying progression of T1DM and its complications.

Keywords: Mediterranean diet; fibers; gut microbiota; short-chain fatty acids; type 1 diabetes mellitus.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2021 Calabrese, Valentini and Calabrese.

Figures

Figure 1
Figure 1
Mediterranean diet (MD) induces changes in gut microbiota by promoting the growing of taxa which contribute to a greater formation of short-chai fatty acids (SCFAs) and to a lower production of trimethylamine N-oxide (TMAO), leading to a delay in the progression of type 1 diabetes mellitus (T1DM) and in the development of cardiovascular complications.

References

    1. American Diabetes Association . Classification and diagnosis of diabetes: standards of medical care in diabetes −2020. Diabetes Care. (2020) 43 (Suppl. 1):S14–31. 10.2337/dc20-S002
    1. Ilonen J, Lempainen J, Veijola R. The heterogeneous pathogenesis of type 1 diabetes mellitus. Nat Rev Endocrinol. (2019) 15:635–50. 10.1038/s41574-019-0254-y
    1. Di Meglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. (2018) 391:2449–62. 10.1016/S0140-6736(18)31320-5
    1. Acharjee S, Ghosh B, Al-Dhubiab BE, Nair AB. Understanding type 1 diabetes: etiology and models. Can J Diabetes. (2013) 37:269–76. 10.1016/j.jcjd.2013.05.001
    1. Ounissi-Benkalha H, Polychronakos C. The molecular genetics of type 1 diabetes: new genes and emerging mechanisms. Trends Mol Med. (2008) 14:268–75. 10.1016/j.molmed.2008.04.002
    1. Nyaga DM, Vickers MH, Jefferies C, Perry JK, O'Sullivan JM. The genetic architecture of type 1 diabetes mellitus. Mol Cell Endocrinol. (2018) 477:70–80. 10.1016/j.mce.2018.06.002
    1. Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature. (2010) 464:1293–300. 10.1038/nature08933
    1. Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med. (2009) 360:1646–54. 10.1056/NEJMra0808284
    1. Cerna M. Epigenetic regulation in etiology of type 1 diabetes mellitus. Int J Mol Sci. (2019) 21:36. 10.3390/ijms21010036
    1. Pociot F, Lernmark Å. Genetic risk factors for type 1 diabetes. Lancet. (2016) 387:2331–9. 10.1016/S0140-6736(16)30582-7
    1. Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. (2014) 383:69–82. 10.1016/S0140-6736(13)60591-7
    1. Rewers M, Ludvigsson J. Environmental risk factors for type 1 diabetes. Lancet. (2016) 387:2340–8. 10.1016/S0140-6736(16)30507-4
    1. Norris JM, Johnson RK, Stene LC. Type 1 diabetes-early life origins and changing epidemiology. Lancet Diabetes Endocrinol. (2020) 8:226–38. 10.1016/S2213-8587(19)30412-7
    1. Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ. (2011) 342:d35. 10.1136/bmj.d35
    1. Laitinen OH, Honkanen H, Pakkanen O, Oikarinen S, Hankaniemi MM, Huhtala H, et al. . Coxsackievirus B1 is associated with induction of β-cell autoimmunity that portends type 1 diabetes. Diabetes. (2014) 63:446–55. 10.2337/db13-0619
    1. Esposito S, Toni G, Tascini G, Santi E, Berioli MG, Principi N. Environmental factors associated with type 1 diabetes. Front Endocrinol. (2019) 10:592. 10.3389/fendo.2019.00592
    1. Virtanen SM. Dietary factors in the development of type 1 diabetes. Pediatr Diabetes. (2016) 17 (Suppl. 22):49–55. 10.1111/pedi.12341
    1. Nielsen DS, Krych Ł, Buschard K, Hansen CH, Hansen AK. Beyond genetics influence of dietary factors and gut microbiota on type 1 diabetes. FEBS Lett. (2014) 588:4234–43. 10.1016/j.febslet.2014.04.010
    1. Virtanen SM, Nevalainen J, Kronberg-Kippilä C, Ahonen S, Tapanainen H, Uusitalo L, et al. . Food consumption and advanced β cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes: a nested case-control design. Am J Clin Nutr. (2012) 95:471–8. 10.3945/ajcn.111.018879
    1. Muntoni S, Cocco P, Aru G, Cucca F. Nutritional factors and worldwide incidence of childhood type 1 diabetes. Am J Clin Nutr. (2000) 71:1525–9. 10.1093/ajcn/71.6.1525
    1. Norris JM, Yin X, Lamb MM, Barriga K, Seifert J, Hoffman M, et al. . Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes. JAMA. (2007) 298:1420–8. 10.1001/jama.298.12.1420
    1. Bi X, Li F, Liu S, Jin Y, Zhang X, Yang T, et al. . ω-3 polyunsaturated fatty acids ameliorate type 1 diabetes and autoimmunity. J Clin Invest. (2017) 127:1757–71. 10.1172/JCI87388
    1. Leeming ER, Johnson AJ, Spector TD, Le Roy CI. Effect of diet on the gut microbiota: rethinking intervention duration. Nutrients. (2019) 11:2862. 10.3390/nu11122862
    1. Zheng P, Li Z, Zhou Z. Gut microbiome in type 1 diabetes: a comprehensive review. Diabetes Metab Res Rev. (2018) 34:e3043. 10.1002/dmrr.3043
    1. Putignani L, Del Chierico F, Petrucca A, Vernocchi P, Dallapiccola B. The human gut microbiota: a dynamic interplay with the host from birth to senescence settled during childhood. Pediatr Res. (2014) 76:2–10. 10.1038/pr.2014.49
    1. Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol Life Sci. (2019) 76:473–93. 10.1007/s00018-018-2943-4
    1. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. . Enterotypes of the human gut microbiome. Nature. (2011) 473:174–80. 10.1038/nature09944
    1. Jardine M. Nutrition considerations for microbiota health in diabetes. Diabetes Spectr. (2016) 29:238–44. 10.2337/ds16-0003
    1. Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. (2017) 474:1823–36. 10.1042/BCJ20160510
    1. Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D. Role of the normal gut microbiota. World J Gastroenterol. (2015) 21:8787–803. 10.3748/wjg.v21.i29.8787
    1. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev. (2010) 90:859–904. 10.1152/physrev.00045.2009
    1. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. (2012) 336:1268–73. 10.1126/science.1223490
    1. Rowland I, Gibson G, Heinken A, Scott K, Swann J, Thiele I, et al. Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr. (2018) 57:1–24. 10.1007/s00394-017-1445-8
    1. Davis-Richardson AG, Triplett EW. A model for the role of gut bacteria in the development of autoimmunity for type 1 diabetes. Diabetologia. (2015) 58:1386–93. 10.1007/s00125-015-3614-8
    1. Vinolo MA, Rodrigues HG, Nachbar RT, Curi R. Regulation of inflammation by short chain fatty acids. Nutrients. (2011) 3:858–76. 10.3390/nu3100858
    1. Luu M, Visekruna A. Short-chain fatty acids: Bacterial messengers modulating the immunometabolism of T cells. Eur J Immunol. (2019) 49:842–8. 10.1002/eji.201848009
    1. Vinolo MA, Rodrigues HG, Hatanaka E, Sato FT, Sampaio SC, Curi R. Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J Nutr Biochem. (2011) 22:849–55. 10.1016/j.jnutbio.2010.07.009
    1. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, et al. . Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature. (2008) 455:1109–13. 10.1038/nature07336
    1. Jamshidi P, Hasanzadeh S, Tahvildari A, Farsi Y, Arbabi M, Mota JF, et al. . Is there any association between gut microbiota and type 1 diabetes? a systematic review. Gut Pathog. (2019) 11:49. 10.1186/s13099-019-0332-7
    1. Alkanani AK, Hara N, Gottlieb PA, Ir D, Robertson CE, Wagner BD, et al. . Alterations in intestinal microbiota correlate with susceptibility to type 1 diabetes. Diabetes. (2015) 64:3510–20. 10.2337/db14-1847
    1. Paun A, Yau C, Danska JS. Immune recognition and response to the intestinal microbiome in type 1 diabetes. J Autoimmun. (2016) 71:10–8. 10.1016/j.jaut.2016.02.004
    1. Murri M, Leiva I, Gomez-Zumaquero JM, Tinahones FJ, Cardona F, Soriguer F, et al. . Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med. (2013) 11:46. 10.1186/1741-7015-11-46
    1. Giongo A, Gano KA, Crabb DB, Mukherjee N, Novelo LL, Casella G, et al. . Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. (2011) 5:82–91. 10.1038/ismej.2010.92
    1. Nakamura Y, Nagai Y, Kobayashi T, Furukawa K, Oikawa Y, Shimada A, et al. . Characteristics of gut microbiota in patients with diabetes determined by data mining analysis of terminal restriction fragment length polymorphisms. J Clin Med Res. (2019) 11:401–6. 10.14740/jocmr3791
    1. de Goffau MC, Luopajärvi K, Knip M, Ilonen J, Ruohtula T, Härkönen T, et al. . Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes. (2013) 62:1238–44. 10.2337/db12-0526
    1. Knip M, Siljander H. The role of the intestinal microbiota in type 1 diabetes mellitus. Nat Rev Endocrinol. (2016) 12:154–67. 10.1038/nrendo.2015.218
    1. Dedrick S, Sundaresh B, Huang Q, Brady C, Yoo T, Cronin C, et al. . The role of gut microbiota and environmental factors in type 1 diabetes pathogenesis. Front Endocrinol. (2020) 11:78. 10.3389/fendo.2020.00078
    1. Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, Roy NC. Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr. (2011) 141:769–76. 10.3945/jn.110.135657
    1. den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. (2013) 54:2325–40. 10.1194/jlr.R036012
    1. Brown CT, Davis-Richardson AG, Giongo A, Gano KA, Crabb DB, Mukherjee N, et al. . Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS ONE. (2011) 6:e25792. 10.1371/journal.pone.0025792
    1. Endesfelder D, Engel M, Davis-Richardson AG, Ardissone AN, Achenbach P, Hummel S, et al. Towards a functional hypothesis relating anti-islet cell autoimmunity to the dietary impact on microbial communities and butyrate production. Microbiome. (2016) 4:17 10.1186/s40168-016-0163-4
    1. Bibbò S, Dore MP, Pes GM, Delitala G, Delitala AP. Is there a role for gut microbiota in type 1 diabetes pathogenesis? Ann Med. (2017) 49:11–22. 10.1080/07853890.2016.1222449
    1. Bosi E, Molteni L, Radaelli MG, Folini L, Fermo I, Bazzigaluppi E, et al. . Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia. (2006) 49:2824–7. 10.1007/s00125-006-0465-3
    1. Gavin PG, Mullaney JA, Loo D, Cao KL, Gottlieb PA, Hill MM, et al. . Intestinal metaproteomics reveals host-microbiota interactions in subjects at risk for type 1 diabetes. Diabetes Care. (2018) 41:2178–86. 10.2337/dc18-0777
    1. Ahuja M, Schwartz DM, Tandon M, Son A, Zeng M, Swaim W, et al. . Orai1-mediated antimicrobial secretion from pancreatic acini shapes the gut microbiome and regulates gut innate immunity. Cell Metab. (2017) 25:635–46. 10.1016/j.cmet.2017.02.007
    1. Miani M, Le Naour J, Waeckel-Enée E, Verma SC, Straube M, Emond P, et al. . Gut microbiota-stimulated innate lymphoid cells support β-defensin 14 expression in pancreatic endocrine cells, preventing autoimmune diabetes. Cell Metab. (2018) 28:557–72. 10.1016/j.cmet.2018.06.012
    1. Pound LD, Patrick C, Eberhard CE, Mottawea W, Wang GS, Abujamel T, et al. . Cathelicidin antimicrobial peptide: a novel regulator of islet function, islet regeneration, and selected gut bacteria. Diabetes. (2015) 64:4135–47. 10.2337/db15-0788
    1. Stenwall A, Ingvast S, Skog O, Korsgren O. Characterization of host defense molecules in the human pancreas. Islets. (2019) 11:89–101. 10.1080/19382014.2019.1585165
    1. Sun J, Xu M, Ortsäter H, Lundeberg E, Juntti-Berggren L, Chen YQ, et al. . Cathelicidins positively regulate pancreatic β-cell functions. FASEB J. (2016) 30:884–94. 10.1096/fj.15-275826
    1. Sun J, Furio L, Mecheri R, van der Does AM, Lundeberg E, Saveanu L, et al. . Pancreatic β-cells limit autoimmune diabetes via an immunoregulatory antimicrobial peptide expressed under the influence of the gut microbiota. Immunity. (2015) 43:304–17. 10.1016/j.immuni.2015.07.013
    1. Brauner H, Lüthje P, Grünler J, Ekberg NR, Dallner G, Brismar K, et al. . Markers of innate immune activity in patients with type 1 and type 2 diabetes mellitus and the effect of the anti-oxidant coenzyme Q10 on inflammatory activity. Clin Exp Immunol. (2014) 177:478–82. 10.1111/cei.12316
    1. Keys A, Aravanis C, Blackburn H, Buzina R, Djordjevic BS, Dontas AS, et al. Seven Countries Study. A Multivariate Analysis of Death and Coronary Heart Disease. Cambridge, MA: Harvard University Press; (1980).
    1. Kromhout D, Menotti A, Blackburn H. Prevention of Coronary Heart Disease. Diet, Lifestyle and Risk Factors in the Seven Countries Study. Norwell, MA; Dordrecht: Kluwer; (2002).
    1. Campbell Colin T, Jacobson H. The Low-carb Fraud. Dallas, TX: BenBella Books, Inc; (2014).
    1. Dernini S, Berry EM, Serra-Majem L, La Vecchia C, Capone R, Medina FX, et al. . Med diet 4.0: the Mediterranean diet with four sustainable benefits. Public Health Nutr. (2017) 20:1322–30. 10.1017/S1368980016003177
    1. Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr. (2010) 92:1189–96. 10.3945/ajcn.2010.29673
    1. Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Adherence to Mediterranean diet and health status: meta-analysis. BMJ. (2008) 337:a1344. 10.1136/bmj.a1344
    1. D'Alessandro A, De Pergola G. The Mediterranean diet: its definition and evaluation of a priori dietary indexes in primary cardiovascular prevention. Int J Food Sci Nutr. (2018) 69:647–59. 10.1080/09637486.2017.1417978
    1. Vitiello V, Germani A, Capuzzo Dolcetta E, Donini LM, Del Balzo V. The new modern Mediterranean Diet italian pyramid. Ann Ig. (2016) 28:179–86. 10.7416/ai.2016.2096
    1. Davis C, Bryan J, Hodgson J, Murphy K. Definition of the Mediterranean diet; a Literature Review. Nutrients. (2015) 7:9139–53. 10.3390/nu7115459
    1. Willett WC, Sacks F, Trichopoulou A, Drescher G, Ferro-Luzzi A, Helsing E, et al. . Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr. (1995) 61 (Suppl. 6):1402S−6. 10.1093/ajcn/61.6.1402S
    1. Yubero-Serrano EM, Lopez-Moreno J, Gomez-Delgado F, Lopez-Miranda J. Extra virgin olive oil: More than a healthy fat. Eur J Clin Nutr. (2019) 72 (Suppl. 1):8–17. 10.1038/s41430-018-0304-x
    1. Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med. (2018) 378:e34 10.1056/NEJMoa1800389
    1. Hidalgo M, Prieto I, Abriouel H, Cobo A, Benomar N, Gálvez A, et al. . Effect of virgin and refined olive oil consumption on gut microbiota. Comparison to butter. Food Res Int. (2014) 64:553–9. 10.1016/j.foodres.2014.07.030
    1. Zhao Z, Shi A, Wang Q, Zhou J. High oleic acid peanut oil and extra virgin olive oil supplementation attenuate metabolic syndrome in rats by modulating the gut microbiota. Nutrients. (2019) 11:3005. 10.3390/nu11123005
    1. Prieto I, Hidalgo M, Segarra AB, Martínez-Rodríguez AM, Cobo A, Ramírez M, et al. . Influence of a diet enriched with virgin olive oil or butter on mouse gut microbiota and its correlation to physiological and biochemical parameters related to metabolic syndrome. PLoS ONE. (2018) 13:e0190368. 10.1371/journal.pone.0190368
    1. Rodríguez-García C, Sánchez-Quesada C, Algarra I, Gaforio JJ. The high-fat diet based on extra-virgin olive oil causes dysbiosis linked to colorectal cancer prevention. Nutrients. (2020) 12:1705. 10.3390/nu12061705
    1. Marcelino G, Hiane PA, Freitas KC, Santana LF, Pott A, Donadon JR, et al. . Effects of olive oil and its minor components on cardiovascular diseases, inflammation, and gut microbiota. Nutrients. (2019) 11:1826. 10.3390/nu11081826
    1. Wang Z, Roberts AB, Buffa JA, Levison BS, Zhu W, Org E, et al. . Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell. (2015) 163:1585–95. 10.1016/j.cell.2015.11.055
    1. Ufnal M, Zadlo A, Ostaszewski R. TMAO: A small molecule of great expectations. Nutrition. (2015) 31:1317–23. 10.1016/j.nut.2015.05.006
    1. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al. . Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. (2013) 19:576–85. 10.1038/nm.3145
    1. Obeid R, Awwad HM, Rabagny Y, Graeber S, Herrmann W, Geisel J. Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism. Am J Clin Nutr. (2016) 103:703–11. 10.3945/ajcn.115.121269
    1. Winther SA, Øllgaard JC, Tofte N, Tarnow L, Wang Z, Ahluwalia TS, et al. . Utility of plasma concentration of trimethylamine N-Oxide in predicting cardiovascular and renal complications in individuals with type 1 diabetes. Diabetes Care. (2019) 42:1512–20. 10.2337/dc19-0048
    1. Kay RM. Dietary fiber. J Lipid Res. (1982) 23:221–42. 10.1111/j.1365-2044.1982.tb01080.x
    1. Mudgil D, Barak S. Composition, properties and health benefits of indigestible carbohydrate polymers as dietary fiber: a review. Int J Biol Macromol. (2013) 61:1–6. 10.1016/j.ijbiomac.2013.06.044
    1. Slavin J. Fiber and prebiotics: mechanisms and health benefits. Nutrients. (2013) 5:1417–35. 10.3390/nu5041417
    1. Capuano E. The behavior of dietary fiber in the gastrointestinal tract determines its physiological effect. Crit Rev Food Sci Nutr. (2017) 57:3543–64. 10.1080/10408398.2016.1180501
    1. O'Grady J, O'Connor EM, Shanahan F. Review article: dietary fibre in the era of microbiome science. Aliment Pharmacol Ther. (2019) 49:506–15. 10.1111/apt.15129
    1. Holscher HD. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes. (2017) 8:172–84. 10.1080/19490976.2017.1290756
    1. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. (1995) 125:1401–12. 10.1093/jn/125.6.1401
    1. Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev. (2004) 17:259–75. 10.1079/NRR200479
    1. Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gómez-Llorente C, Gil A. Probiotic mechanisms of action. Ann Nutr Metab. (2012) 61:1601–74. 10.1159/000342079
    1. Reid G. Probiotics: definition, scope and mechanisms of action. Best Pract Res Clin Gastroenterol. (2016) 30:17–25. 10.1016/j.bpg.2015.12.001
    1. Liu Y, Tran DQ, Rhoads JM. Probiotics in disease prevention and treatment. J Clin Pharmacol. (2018) 58 (Suppl. 10):S164–79. 10.1002/jcph.1121
    1. Tosti V, Bertozzi B, Fontana L. Health benefits of the mediterranean diet: metabolic and molecular mechanisms. J Gerontol A Biol Sci Med Sci. (2018) 73:318–26. 10.1093/gerona/glx227
    1. Nagpal R, Shively CA, Register TC, Craft S, Yadav H. Gut microbiome-Mediterranean diet interactions in improving host health. F1000Res. (2019) 8:699. 10.12688/f1000research.18992.1
    1. De F, Pellegrini N, Vannini L, Jeffery IB, La Storia A, Laghi L, et al. . High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut. (2016) 65:1812–21. 10.1136/gutjnl-2015-309957
    1. Mitsou EK, Kakali A, Antonopoulou S, Mountzouris KC, Yannakoulia M, Panagiotakos DB, et al. . Adherence to the Mediterranean diet is associated with the gut microbiota pattern and gastrointestinal characteristics in an adult population. Br J Nutr. (2017) 117:1645–55. 10.1017/S0007114517001593
    1. Gutiérrez-Díaz I, Fernández-Navarro T, Salazar N, Bartolomé B, Moreno-Arribas MV, de Andres-Galiana EJ, et al. . Adherence to a Mediterranean diet influences the fecal metabolic profile of microbial-derived phenolics in a Spanish cohort of middle-age and older people. J Agric Food Chem. (2017) 65:586–95. 10.1021/acs.jafc.6b04408
    1. Tindall AM, Petersen KS, Kris-Etherton PM. Dietary patterns affect the gut microbiome-the link to risk of cardiometabolic diseases. J Nutr. (2018) 148:1402–7. 10.1093/jn/nxy141
    1. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, et al. . Linking long-term dietary patterns with gut microbial enterotypes. Science. (2011) 334:105–8. 10.1126/science.1208344
    1. Saura-Calixto F, Goñi I. Definition of the Mediterranean diet based on bioactive compounds. Crit Rev Food Sci Nutr. (2009) 49:145–52. 10.1080/10408390701764732
    1. Kitts DD. Bioactive substances in food: identification and potential uses. Can J Physiol Pharmacol. (1994) 72:423–34. 10.1139/y94-062
    1. Kris-Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkoski AE, Hilpert KF, et al. . Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med. (2002) 113 (Suppl. 9B):71S−88. 10.1016/S0002-9343(01)00995-0
    1. Silva LBAR, Pinheiro-Castro N, Novaes GM, Pascoal GFL, Ong TP. Bioactive food compounds, epigenetics and chronic disease prevention: Focus on early-life interventions with polyphenols. Food Res Int. (2019) 125:108646. 10.1016/j.foodres.2019.108646
    1. Rawshani A, Rawshani A, Franzén S, Eliasson B, Svensson AM, Miftaraj M, et al. . Range of risk factor levels: control, mortality, and cardiovascular outcomes in type 1 diabetes mellitus. Circulation. (2017) 135:1522–31. 10.1161/CIRCULATIONAHA.116.025961
    1. Leroux C, Brazeau AS, Gingras V, Desjardins K, Strychar I, Rabasa-Lhoret R. Lifestyle and cardiometabolic risk in adults with type 1 diabetes: a review. Can J Diabetes. (2014) 38:62–9. 10.1016/j.jcjd.2013.08.268
    1. Martínez-González MA, Gea A, Ruiz-Canela M. The mediterranean diet and cardiovascular health. Circ Res. (2019) 124:779–98. 10.1161/CIRCRESAHA.118.313348
    1. Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The task force on diabetes and cardiovascular diseases of the European society of cardiology (ESC) and of the European association for the study of diabetes (EASD). Eur Heart J. (2007) 28:88–136. 10.1093/eurheartj/ehl260
    1. Pereira MA, O'Reilly E, Augustsson K, Fraser GE, Goldbourt U, Heitmann BL, et al. . Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med. (2004) 164:370–6. 10.1001/archinte.164.4.370
    1. Overby NC, Flaaten V, Veierød MB, Bergstad I, Margeirsdottir HD, Dahl-Jørgensen K, et al. . Children and adolescents with type 1 diabetes eat a more atherosclerosis-prone diet than healthy control subjects. Diabetologia. (2007) 50:307–16. 10.1007/s00125-006-0540-9
    1. Schoenaker DA, Toeller M, Chaturvedi N, Fuller JH, Soedamah-Muthu SS, EURODIAB Prospective Complications Study Group . Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB prospective complications study. Diabetologia. (2012) 55:2132–41. 10.1007/s00125-012-2550-0
    1. Zhong VW, Lamichhane AP, Crandell JL, Couch SC, Liese AD, The NS. Association of adherence to a Mediterranean diet with glycemic control and cardiovascular risk factors in youth with type I diabetes: the SEARCH nutrition ancillary study. Eur J Clin Nutr. (2016) 70:802–7. 10.1038/ejcn.2016.8
    1. Maslowski KM, Mackay CR. Diet, gut microbiota and immune responses. Nat Immunol. (2011) 12:5–9. 10.1038/ni0111-5
    1. Mejía-León ME, Barca AM. Diet, microbiota and immune system in type 1 diabetes development and evolution. Nutrients. (2015) 7:9171–84. 10.3390/nu7115461
    1. Gentile CL, Weir TL. The gut microbiota at the intersection of diet and human health. Science. (2018) 362:776–80. 10.1126/science.aau5812
    1. Ghosh TS, Rampelli S, Jeffery IB, Santoro A, Neto M, Capri M, et al. . Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries. Gut. (2020) 69:1218–28. 10.1136/gutjnl-2019-319654
    1. Bailey MA, Holscher HD. Microbiome-mediated effects of the Mediterranean Diet on Inflammation. Adv Nutr. (2018) 9:193–206. 10.1093/advances/nmy013
    1. Bach Knudsen KE, Lærke HN, Hedemann MS, Nielsen TS, Ingerslev AK, Gundelund Nielsen DS, et al. . Impact of diet-modulated butyrate production on intestinal barrier function and inflammation. Nutrients. (2018) 10:1499. 10.3390/nu10101499
    1. Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol. (2011) 17:1519–28. 10.3748/wjg.v17.i12.1519
    1. Gomes AC, Bueno AA, de Souza RG, Mota JF. Gut microbiota, probiotics and diabetes. Nutr J. (2014) 13:60. 10.1186/1475-2891-13-60
    1. Valladares R, Sankar D, Li N, Williams E, Lai KK, Abdelgeliel AS, et al. . Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS ONE. (2010) 5:e10507. 10.1371/journal.pone.0010507

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe